SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Advanced Viral Research CP (ADVR)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: joe blow23 who wrote (1920)12/28/1996 12:30:00 PM
From: maho   of 2281
 
Part of being a CEO is to keep the stockholders imformed about any changes in the compsany and or current status of ongoing tests, current mrketing pending or not agreements and the status of future sales of the drug if in fact they are currently trying to get f.d.a. approval of this drug. Also i find it very hard to swallow that the d.r. is to busy doing other things that he cannot dictate a letter to the shareholders which probably would take no longer than an hour, dont you agree? I think that we deserve as much because its guys like me or you who infact support this company with our hard earned dollars, and thats not to say that i own a lot of stock, but if you combine what amount of stock that the average investor owns i will make a bet that we as a hole own more than the current people inside the company own, so you can throw that argument out the window, The new CEO owes us a letter pertaining to the current testing and upon completion of that testing the direction to which he expects to lead this company
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News